Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
IDIDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA)

NASDAQ Global Select · Currency in USD
$34.71 ▼ -1.41 (-3.90%)
At close: Oct 23, 4:00 PM ET. Market closed.
$34.71 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$36.12
Open
$36.35
Day's Range
$34.54 – $36.35
52 Week Range
$26.81 – $42.68
Volume
1,128,963
Avg. Volume
929,505
Market Cap
$3.35B
Beta (5Y Monthly)
-0.09
PE Ratio (TTM)
--
EPS (TTM)
-$1.90
Earnings Date
Nov 9, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$57.00

Profile: IDEAYA Biosciences, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
145
CEO
Yujiro S. Hata

IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs.

Earnings

Next report: Mon, Nov 9, 2026
EPS estimate -$1.17 · Revenue est. $7.58M
DateEst.Actual
Aug 4, 2026-$1.06-$1.22Miss
May 5, 2026-$1.07-$1.11Miss
Feb 17, 2026-$0.95-$0.94Beat
Nov 4, 2025-$0.95$1.33Beat
Aug 5, 2025-$0.85-$0.88Miss
May 6, 2025-$0.75-$0.82Miss

Analyst view

Consensus price target
$57.00 ▲ +64.2%
Range $48.00 – $63.00
Rating: Buy
Buy 92% · Hold 8% · Sell 0%

Get free alerts on IDYA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.